? CLINICAL TRANSLATIONAL CORE The Clinical/Translational Core provides an infrastructure and resources for human translational and patient- oriented research. This is accomplished in part by providing translational resources for liver investigators who are basic scientists, such as making bio-specimens available and offering iPSC?s/liver organoids derived from patients with specific diseases. The Core is useful for clinical researchers as well, who also make use of bio- specimens and our patient registry, plus the services of our research coordinator and statisticians. Therefore, the Clinical/Translational Core advances the science and practice of Hepatology through the following specific aims: (1) Provide resources necessary to support clinical and translational research, specifically: (a) biostatistical support, including study design and data analysis, with plans to increase expertise in database research, (b) bioinformatic support, including analysis and interpretation of whole-exome and whole-genome sequencing, RNA-seq, single cell RNA-seq, microRNA-seq, ChIP-seq, and 16S/18S and shotgun metagenomics, (c) patient registry and biospecimen repository, with recent extension of this repository to include peripheral blood mononuclear cells (PBMC) that can be transformed into iPSCs, as well as human bile, both of which can be used in the creation of liver organoids, and (d) staff support, including a research coordinator who can help locate/retrieve biospecimens from the liver center repository or from other relevant repositories at our institution, and a liver pathologist, who is available for consultation, retrieval and review of archived clinical specimens, and interpretation of other tissue specimens, such as from animal models. (2) Provide the environment in which high-quality clinical and translational research will be centered, thereby translating knowledge from basic science to clinical research, contributing to the development of young clinical investigators and creating collaborations among center members and other members of the scientific community interested in research relevant to liver. As a result of these efforts, half of the members who now use this core are laboratory- based investigators, and all center members who currently use this core collaborate with other center members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK034989-36A1
Application #
10048272
Study Section
Special Emphasis Panel (ZDK1)
Project Start
1997-09-30
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
36
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Strazzabosco, Mario; Fiorotto, Romina; Cadamuro, Massimiliano et al. (2018) Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. Biochim Biophys Acta Mol Basis Dis 1864:1374-1379
Murugesan, Vagishwari; Liu, Jun; Yang, Ruhua et al. (2018) Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. Blood Cells Mol Dis 68:47-53
Sachar, Hamita; Pichetshote, Nipaporn; Nandigam, Kavitha et al. (2018) Continued midazolam versus diphenhydramine in difficult-to-sedate patients: a randomized double-blind trial. Gastrointest Endosc 87:1297-1303
Bhutta, A Q; Garcia-Tsao, G; Reddy, K R et al. (2018) Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation. Aliment Pharmacol Ther 47:78-85
Kuo, Andrew; Lee, Monica Y; Yang, Kui et al. (2018) Caveolin-1 regulates lipid droplet metabolism in endothelial cells via autocrine prostacyclin-stimulated, cAMP-mediated lipolysis. J Biol Chem 293:973-983
Hollister, Kristin; Kusumanchi, Praveen; Ross, Ruth Ann et al. (2018) Levels of circulating follicular helper T cells, T helper 1 cells, and the prognostic significance of soluble form of CD40 ligand on survival in patients with alcoholic cirrhosis. Liver Res 2:52-59
Garcia-Tsao, Guadalupe (2018) Management of Acute Variceal Hemorrhage as a Model of Individualized Care for Patients With Cirrhosis. Clin Gastroenterol Hepatol 16:24-26
Fonseca, Matheus de Castro; França, Andressa; Florentino, Rodrigo Machado et al. (2018) Cholesterol-enriched membrane microdomains are needed for insulin signaling and proliferation in hepatic cells. Am J Physiol Gastrointest Liver Physiol 315:G80-G94
Chang, Binxia; Hao, Shuli; Zhang, Longyu et al. (2018) Association Between Aldehyde Dehydrogenase 2 Glu504Lys Polymorphism and Alcoholic Liver Disease. Am J Med Sci 356:10-14
Sullivan, Rebecca; Abraham, Alice; Simpson, Christine et al. (2018) Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia. Calcif Tissue Int 102:666-670

Showing the most recent 10 out of 763 publications